OBX
Obsidian Therapeutics Inc.
NASDAQ · Healthcare · Biotechnology · US
$16.82
−1.58%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
—
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Aug 5, 2026 | ROSS ROBERT W. · director | A-Award | 37,653 | $12 |
| Aug 5, 2026 | Norkunas Matthew · director | A-Award | 37,653 | $12 |
| Aug 5, 2026 | Jagasia Madan · director, officer: Chief Executive Officer | A-Award | 37,653 | $12 |
| Aug 5, 2026 | Barrett Peter · director | A-Award | 37,653 | $12 |
| Aug 5, 2026 | Hagen Heidi · director | A-Award | 37,653 | $12 |
| Aug 5, 2026 | Fardis Maria · director | A-Award | 37,653 | $12 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 5, 2026